Paper38717954
Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment.
Shornale Akter M and 9 others. Cancer Rep (Hoboken), 2024. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment. Papers, record 38717954. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38717954
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Biomarkers, Tumor | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Gene Expression Profiling | Major topic |
| Humans | |
| Female | |
| Molecular Docking Simulation | |
| Antineoplastic Agents | |
| Protein Interaction Maps | |
| MicroRNAs | |
| Transcriptome | |
| Gene Regulatory Networks | |
| Signal Transduction |
Source PubMed
References87
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34059798 | The PTEN and ATM axis controls the G1/S cell cycle checkpoint and tumorigenesis in HER2-positive breast cancer. | Cell Death Differ | 2021 | https://conductscience.org/library/papers/34059798 | PubMed |
| 2 | 36313438 | A genomic and transcriptomic study toward breast cancer. | Front Genet | 2022 | https://conductscience.org/library/papers/36313438 | PubMed |
| 3 | 32269634 | ZNF24 is upregulated in prostate cancer and facilitates the epithelial-to-mesenchymal transition through the regulation of Twist1. | Oncol Lett | 2020 | https://conductscience.org/library/papers/32269634 | PubMed |
| 4 | 32462972 | Circular RNA hsa_circ_0000376 Participates in Tumorigenesis of Breast Cancer by Targeting miR-1285-3p. | Technol Cancer Res Treat | 2020 | https://conductscience.org/library/papers/32462972 | PubMed |
| 5 | 32211045 | Signal Transduction Pathways in Breast Cancer: The Important Role of PI3K/Akt/mTOR. | J Oncol | 2020 | https://conductscience.org/library/papers/32211045 | PubMed |
| 6 | 30371825 | PubChem 2019 update: improved access to chemical data. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/30371825 | PubMed |
| 7 | 32203934 | Regulation of docetaxel chemosensitivity by NR2F6 in breast cancer. | Endocr Relat Cancer | 2020 | https://conductscience.org/library/papers/32203934 | PubMed |
| 8 | 30288111 | Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy. | Cancer Manag Res | 2018 | https://conductscience.org/library/papers/30288111 | PubMed |
| 9 | 31799611 | The activating transcription factor 2: an influencer of cancer progression. | Mutagenesis | 2019 | https://conductscience.org/library/papers/31799611 | PubMed |
| 10 | 21217834 | Discovery and preclinical validation of salivary transcriptomic and proteomic biomarkers for the non-invasive detection of breast cancer. | PLoS One | 2010 | https://conductscience.org/library/papers/21217834 | PubMed |
| 11 | 25618350 | Small-molecule library screening by docking with PyRx. | Methods Mol Biol | 2015 | https://conductscience.org/library/papers/25618350 | PubMed |
| 12 | 34638457 | Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34638457 | PubMed |
| 13 | 25521941 | cytoHubba: identifying hub objects and sub-networks from complex interactome. | BMC Syst Biol | 2014 | https://conductscience.org/library/papers/25521941 | PubMed |
| 14 | 29449899 | FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles. | Ther Adv Med Oncol | 2017 | https://conductscience.org/library/papers/29449899 | PubMed |
| 15 | 23586463 | Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. | BMC Bioinformatics | 2013 | https://conductscience.org/library/papers/23586463 | PubMed |
| 16 | 15028117 | VisANT: an online visualization and analysis tool for biological interaction data. | BMC Bioinformatics | 2004 | https://conductscience.org/library/papers/15028117 | PubMed |
| 17 | 18790636 | Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors. | Bioorg Med Chem Lett | 2008 | https://conductscience.org/library/papers/18790636 | PubMed |
| 18 | 14733031 | Breast cancer: a review of the literature. | J Insur Med | 2003 | https://conductscience.org/library/papers/14733031 | PubMed |
| 19 | 25176396 | jvenn: an interactive Venn diagram viewer. | BMC Bioinformatics | 2014 | https://conductscience.org/library/papers/25176396 | PubMed |
| 20 | 26892619 | Trastuzumab in the Treatment of Breast Cancer. | BioDrugs | 2016 | https://conductscience.org/library/papers/26892619 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41548001 | QAL333's antitumor activity and predictive modeling: integrated transcriptomic-bioinformatic analysis reveals selective cytotoxicity and sensitivity determinants. | Sci Rep | 2026 | https://conductscience.org/library/papers/41548001 | PubMed |
| 40907734 | Subtype-specific HER3 enrichment in basal-like breast cancer is regulated via the GATA2/GATA3-FOXA1 axis. | Cancer Lett | 2025 | https://conductscience.org/library/papers/40907734 | PubMed |
| 40660203 | Identification and modulation of a PI3K/AKT/mTOR pathway-targeting microRNA in order to increase colorectal cancer cells radiosensitivity in vitro. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40660203 | PubMed |
| 40558287 | Prognostic Relevance of Inflammatory Cytokines Il-6 and TNF-Alpha in Patients with Breast Cancer: A Systematic Review and Meta-Analysis. | Curr Oncol | 2025 | https://conductscience.org/library/papers/40558287 | PubMed |
| 40229646 | Targeting kinases that regulate programmed cell death: a new therapeutic strategy for breast cancer. | J Transl Med | 2025 | https://conductscience.org/library/papers/40229646 | PubMed |
| 39942749 | Roles of Post-Translational Modifications of Transcription Factors Involved in Breast Cancer Hypoxia. | Molecules | 2025 | https://conductscience.org/library/papers/39942749 | PubMed |
| 38717954 | Transcriptomic analysis revealed potential regulatory biomarkers and repurposable drugs for breast cancer treatment. | Cancer Rep (Hoboken) | 2024 | https://conductscience.org/library/papers/38717954 | PubMed |
Genes14
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/38717954
GET https://conductscience.org/api/papers/v1/38717954/references?page=2